GlassScriptPhysician profile
Denise S Moore
NPI 1144744822
$1,303.11
in general payments reported to CMS, 2019-2025
21 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.56 · 2022: $53.65 · 2023: $434 · 2024: $354 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.28 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $195.63 | 2023-2025 | Farxiga, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $157.41 | 2023-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $153.05 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $126.24 | 2023-2024 | |
| Edwards Lifesciences Corporation | $98.98 | 2024-2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $90.73 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $82.25 | 2021-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $53.02 | 2024-2025 | |
| Boston Scientific Corporation | $47.14 | 2024-2025 | Watchman Flx, General - Atherectomy |
| Exact Sciences Corporation | $37.05 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $35.81 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $33.41 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.40 | 2023 | Xifaxan |
| Abbott Laboratories | $26.63 | 2025 | Freestyle Libre 3 |
| Paratek Pharmaceuticals, INC. | $23.12 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $22.65 | 2025 | Voquezna |
| Masimo Corporation | $19.38 | 2022 | |
| Amgen INC. | $19.29 | 2023 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.56 | 2024 | |
| Insmed, INC. | $15.87 | 2025 | Arikayce |
| Inogen, INC. | $14.49 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.